Drug development strategy on an organizational and cross-industry level

Designing and executing a successful development program: Showcases

Adapting R&D strategy, org structure and process for the COVID-19 pandemic and beyond

Decentralized and hybrid trials: How to propel them into the mainstream

Accelerating decision making and clinical operations: Lessons learned in 2020 

Drug development strategy and operations for novel modalities

Case studies on successful disruption in both large and small organizations

Digitalization and automation of clinical trials and emerging technology: artificial intelligence, machine learning, RWD, mobile tech, wearables, digital twin

Strategies in decision making, from analytics to emotional intelligence, and the impact on the R&D organization

Separating hype from reality in blockchain, AI, digital health and other hot areas

Patient-centric trials: Integrating the voice of the patient, enabling virtual trials, and exploring global home health nursing

Data Privacy best practices and balancing benefits to open data sharing

Leveraging RWE to advance innovative trial design, execution, data collection, and integration

Risk mitigation in vendor selection, contracting, onboarding, and oversight on a global scale

Driving meaningful adoption "beyond the pilot": Implementing and achieving innovation in an organization

Centers of Excellence (CoC) and Hubs to drive internal and external innovation in clinical research

Key clinical research markets and considerations: China, India, and Latin America